ATG7 and hepatocellular carcinoma: miR-375 was able to inhibit the development of HCC by reducing the expression of Yes-associated protein 1 (YAP1), autophagy-related protein 7 (ATG7,) and astrocyte elevated gene-1 (AEG-1).